Grant name: Minor Use Minor Species Development of Drugs (R01)
Funding organization: U.S. Food and Drug Administration (FDA)
Total funding amount: Up to $250,000 per year for three years
Primary objective: To develop new animal drugs for minor uses in major species or for minor species.
Funding frequency: Recurring with multiple application deadlines.
Higher Education Institutions (Public/State Controlled, Private)
Nonprofits (with and without 501(c)(3) status)
For-Profit Organizations (including Small Businesses)
Local, State, and County Governments
Indian/Native American Tribal Governments
Foreign Organizations
Must have an active Investigational New Animal Drug (INAD) file with FDA/CVM.
Must hold a minor use or minor species designation from FDA/CVM.
Development of new animal drugs for minor uses in major species or for minor species.
Studies must support target animal safety or effectiveness, environmental safety, and human food safety.
Applicants must propose studies that contribute to FDA approval of MUMS-designated drugs.
Maximum budget: $250,000 per year for up to three years.
No cost-sharing required.
July 26, 2024
January 31, 2025
July 25, 2025
January 30, 2026
July 24, 2026
January 29, 2027
Must comply with INAD and designation regulations.
All funded studies must adhere to the Federal Food, Drug and Cosmetic Act.
Study protocol reviewed by FDA/CVM must be included.
Appendices with additional required letters and documentation.